High Cardiovascular Risk In Hiv Patients clinical trials

Explore recruiting high cardiovascular risk in hiv patients clinical trials.

Also recruiting in Europe

High Cardiovascular Risk In Hiv Patients trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomised, double-blind, multicenter, placebo-controlled clinical trial of colchicine to reduce coronary artery inflammation in people with HIV. COLCOHIV

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

High Cardiovascular Risk In Hiv Patients trials by city

High Cardiovascular Risk In Hiv Patients in Toronto High Cardiovascular Risk In Hiv Patients in Vancouver High Cardiovascular Risk In Hiv Patients in Montreal High Cardiovascular Risk In Hiv Patients in Calgary High Cardiovascular Risk In Hiv Patients in Edmonton High Cardiovascular Risk In Hiv Patients in Ottawa High Cardiovascular Risk In Hiv Patients in Winnipeg High Cardiovascular Risk In Hiv Patients in Quebec City High Cardiovascular Risk In Hiv Patients in Hamilton High Cardiovascular Risk In Hiv Patients in Kitchener High Cardiovascular Risk In Hiv Patients in London High Cardiovascular Risk In Hiv Patients in Halifax High Cardiovascular Risk In Hiv Patients in New York High Cardiovascular Risk In Hiv Patients in Los Angeles High Cardiovascular Risk In Hiv Patients in Chicago High Cardiovascular Risk In Hiv Patients in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease